Metformin Class Action Settlement 2026 — $5.55M Teva & Granules NDMA Claim by Jul 10

Metformin Class Action Settlement 2026 — $5.55M Teva & Granules NDMA Claim by Jul 10

Pro rata share of $5.55M fund
Max Payout
Jul 10, 2026
Filing Deadline
Yes
Proof Required?
A $5.55 million class action settlement has been reached for people who purchased certain generic metformin medications that may have contained NDMA contamination. The settlement involves metformin products manufactured by Teva Pharmaceuticals, Granules India, and Heritage/Avet between 2015 and 2020. NDMA (N-nitrosodimethylamine) is a potentially harmful chemical that was found in some generic metformin tablets. If you purchased these affected metformin products during the specified time period, you may be eligible for compensation from this settlement fund.

Who Is Eligible?

You may be eligible to file a claim if you:

  • Purchased generic metformin manufactured by Teva Pharmaceuticals, Granules India, or Heritage/Avet
  • Purchases made between 2015 and 2020
  • Must be a U.S. resident at time of purchase
  • Products contained NDMA contamination above acceptable levels

How Much Can You Get?

The settlement creates a $5.55 million fund to compensate eligible class members. The exact amount each person will receive depends on the total number of valid claims filed and the specific products purchased. Details about individual payout amounts are still pending as the settlement process continues.

How to File Your Claim

Filing your claim is quick and easy:

  • Gather documentation of your metformin purchases from 2015-2020
  • Verify your metformin was manufactured by Teva, Granules, or Heritage/Avet
  • Submit your claim before the July 10, 2026 deadline
  • Download Class Action Buddy to easily file your claim and track settlement updates

💡 Easier way: File with Class Action Buddy

Skip the paperwork. Our app auto-fills your claim form with your saved profile and submits it electronically in under 2 minutes.

Download for iPhone Download for Android

Frequently Asked Questions

What is NDMA and why is it dangerous in metformin?

NDMA is a chemical compound that has been classified as a probable human carcinogen. It was found in some generic metformin tablets at levels exceeding acceptable safety limits, leading to recalls and this class action settlement.

How do I know if my metformin was affected by NDMA contamination?

Check the manufacturer information on your metformin bottle or packaging. If it was made by Teva Pharmaceuticals, Granules India, or Heritage/Avet between 2015-2020, it may be covered by this settlement.

What if I don't have my old metformin bottles or receipts?

You may still be able to file a claim. Contact your pharmacy for purchase records, check insurance statements, or consult with your doctor's office for prescription history. The settlement details regarding proof requirements are still being finalized.

Ready to File Your Claim?

We're adding new settlements regularly. Download the app to get notified when this one is available.

Download Class Action Buddy →